Arnav Mehta

Arnav Mehta is a highly accomplished professional in oncology and biomedical research, currently serving as a Venture Partner at The Column Group since November 2024 and as a Visiting Scientist and Postdoctoral Researcher at the Broad Institute of MIT and Harvard since July 2020. Previous roles include Entrepreneur in Residence at Third Rock Ventures, where contributions were made to Clasp Therapeutics and various early-stage oncology and immunology projects, as well as positions in medical oncology at Massachusetts General Hospital and numerous consultancy roles across multiple pharmaceutical companies, including Flare Therapeutics and Asher Biotherapeutics. Arnav Mehta earned a PhD in Biology and Biological Engineering from Caltech, an MD from Duke University's medical school, and a BS in Chemistry and Mathematics from Duke University.